Literature DB >> 3917560

Subcortical degeneration in Alzheimer's disease.

T McDuff, S M Sumi.   

Abstract

Although Alzheimer's disease is generally considered a degenerative disease that primarily affects the cerebral cortex, subcortical structures such as the substantia innominata and certain brainstem nuclei may be involved. In 28 patients with progressive dementia and pathologically confirmed Alzheimer's disease, we found senile (neuritic) plaques and neurofibrillary tangles in the thalamus in 25 patients, in the hypothalamus in 22, and in the mamillary body in 17. The severity of these lesions seemed to be greater in those with presenile onset of dementia, but was not related to the duration of dementia. Alzheimer's disease is a much more diffuse disorder than is usually appreciated.

Entities:  

Mesh:

Year:  1985        PMID: 3917560     DOI: 10.1212/wnl.35.1.123

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.

Authors:  Haruo Hanyu; Soichiro Shimizu; Kentaro Hirao; Hidekazu Kanetaka; Toshihiko Iwamoto; Taishiro Chikamori; Yasuhiro Usui; Akira Yamashina; Kiyoshi Koizumi; Kimihiko Abe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-22       Impact factor: 9.236

Review 2.  Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?

Authors:  Juan F Codocedo; Juvenal A Ríos; Juan A Godoy; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

3.  Size of mamillary bodies in health and disease: useful measurements in neuroradiological diagnosis of Wernicke's encephalopathy.

Authors:  D Sheedy; A Lara; T Garrick; C Harper
Journal:  Alcohol Clin Exp Res       Date:  1999-10       Impact factor: 3.455

4.  Influence of the Circadian System on Disease Severity.

Authors:  Mikhail Litinski; Frank Ajl Scheer; Steven A Shea
Journal:  Sleep Med Clin       Date:  2009-06-01

5.  Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons.

Authors:  Makoto Ishii; Gang Wang; Gianfranco Racchumi; Jonathan P Dyke; Costantino Iadecola
Journal:  J Neurosci       Date:  2014-07-02       Impact factor: 6.167

6.  Molecular features of hypothalamic plaques in Alzheimer's disease.

Authors:  D G Standaert; V M Lee; B D Greenberg; D E Lowery; J Q Trojanowski
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

Review 7.  Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies.

Authors:  Matthew J McGuire; Makoto Ishii
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

Review 8.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

9.  Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid.

Authors:  B Tate; K S Aboody-Guterman; A M Morris; E C Walcott; R E Majocha; C A Marotta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.

Authors:  Frank M Schmidt; Juergen Kratzsch; Hermann-Josef Gertz; Mandy Tittmann; Ina Jahn; Uta-Carolin Pietsch; Udo X Kaisers; Joachim Thiery; Ulrich Hegerl; Peter Schönknecht
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.